Literature DB >> 11592754

Comorbid illness and the early detection of cancer.

E C Gonzalez1, J M Ferrante, D J Van Durme, N Pal, R G Roetzheim.   

Abstract

BACKGROUND: Comorbidity may be associated with later detection of cancer.
METHODS: Incident cases of colorectal, breast, and prostate cancer and melanoma were determined from the 1994 Florida state tumor registry (N = 32,074). The relationship between comorbidity and late stage at diagnosis was examined using multiple logistic regression.
RESULTS: Patients with comorbid conditions had greater odds of late stage diagnosis for each of the four cancers (colorectal, melanoma, breast, and prostate). Higher mortality rates were observed among patients with comorbid illness, not as a result of later stage at diagnosis, but rather due to their underlying disease.
CONCLUSIONS: Comorbidity was associated with later stage diagnosis. Further research is needed to determine mechanisms by which comorbidity might influence stage at diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11592754

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  24 in total

1.  Evaluation of the use of electronic health data to classify four-year mortality risk for older adults undergoing screening colonoscopies.

Authors:  Marie B Synnestvedt; Mark G Weiner
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

Review 2.  Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review.

Authors:  Mark Corkum; Robin Urquhart; Cynthia Kendell; Fred Burge; Geoffrey Porter; Grace Johnston
Journal:  Cancer Causes Control       Date:  2011-11-20       Impact factor: 2.506

Review 3.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

4.  Predictors of quality of life for long-term cancer survivors with preexisting disabling conditions.

Authors:  Heather Becker; Sook Jung Kang; Alexa Stuifbergen
Journal:  Oncol Nurs Forum       Date:  2012-03       Impact factor: 2.172

5.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

6.  Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998-2004): does being Indigenous make a difference?

Authors:  Suzanne P Moore; Isabelle Soerjomataram; Adèle C Green; Gail Garvey; Jennifer Martin; Patricia C Valery
Journal:  Int J Public Health       Date:  2015-10-01       Impact factor: 3.380

7.  The post-treatment experience of cancer survivors with pre-existing cardiopulmonary disease.

Authors:  Heather Becker; Ruth Rechis; Sook Jung Kang; Adama Brown
Journal:  Support Care Cancer       Date:  2010-07-25       Impact factor: 3.603

8.  Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States.

Authors:  Kimberly A Lowe; Mark D Danese; Michelle L Gleeson; Wendy J Langeberg; Juan Ke; Michael A Kelsh
Journal:  J Gastrointest Cancer       Date:  2016-06

9.  Healthy lifestyle impact on breast cancer-specific and all-cause mortality.

Authors:  Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone
Journal:  Breast Cancer Res Treat       Date:  2017-08-31       Impact factor: 4.872

10.  Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.

Authors:  S Yousuf Zafar; Amy P Abernethy; David H Abbott; Steven C Grambow; Jennifer E Marcello; James E Herndon; Krista L Rowe; Jane T Kolimaga; Leah L Zullig; Meenal B Patwardhan; Dawn T Provenzale
Journal:  BMC Cancer       Date:  2008-11-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.